New global roadmap to 2035 targets hypertension and pre-eclampsia in pregnancy
- On 8 October 2026 WHO and partners launched a global roadmap on hypertensive disorders of pregnancy.
- These disorders complicate 10–15% of pregnancies and cause about 42,000 maternal deaths a year.
- The same disorders cause more than 500,000 stillbirths and newborn deaths every year.
- The roadmap notes there are no medicines developed and approved specifically for pre-eclampsia.
On 8 October 2026 the World Health Organization and partners launched the Global roadmap for hypertensive disorders of pregnancy from 2026 to 2035 and beyond at the Society for Maternal-Fetal Medicine Global Conference. These disorders include pre-eclampsia and are among the leading causes of death for pregnant women and their babies.
The numbers
- Hypertensive disorders complicate an estimated 10–15% of pregnancies worldwide.
- They account for about 16% of maternal deaths, roughly 42,000 deaths a year.
- They cause more than 500,000 stillbirths and newborn deaths each year.
Gaps in care and innovation
Many women still lack basic blood-pressure checks, urine protein testing and essential medicines such as aspirin, antihypertensives and magnesium sulfate. The roadmap also highlights an innovation gap: no medicine has been specifically developed and approved by regulators to prevent or treat pre-eclampsia or eclampsia, while research money has mostly gone to diagnostics. In May 2026 WHO brought together more than 140 partners to agree 20 priority research questions.
Also read: First global report measures inequalities in noncommunicable diseases and their risk factors
Effects beyond birth
Women who had these disorders face higher later risks of chronic hypertension, heart disease, stroke and kidney disease, and exposed children can face risks linked to preterm birth. WHO asks governments, funders and researchers to align around one goal: getting proven interventions to the women and babies who need them most.
Source: World Health Organization
This story is relayed from the source named above; responsibility for its content rests with the original source.
FAQ
What is the global roadmap for hypertensive disorders of pregnancy?
The Global roadmap for hypertensive disorders of pregnancy 2026–2035 is a plan launched by WHO and partners in October 2026 to coordinate research, clinical guidance, access to medicines and diagnostics, and accountability.
How common are hypertensive disorders of pregnancy?
According to WHO, hypertensive disorders of pregnancy, including pre-eclampsia, complicate an estimated 10–15% of pregnancies worldwide.
How many deaths do hypertensive disorders of pregnancy cause?
Hypertensive disorders of pregnancy cause about 16% of maternal deaths, roughly 42,000 a year, plus more than 500,000 stillbirths and newborn deaths.
What basic tools help prevent deaths from pre-eclampsia?
Basic tools against pre-eclampsia include blood-pressure measurement, urine protein testing and medicines such as aspirin, antihypertensives and magnesium sulfate, backed by referral and emergency obstetric care.
Does pre-eclampsia affect a woman’s health after birth?
Yes. Women who had pre-eclampsia or another hypertensive disorder of pregnancy face higher later risks of chronic hypertension, cardiovascular disease, stroke and kidney disease.



